Walle, I. V. d., Bracke, L., Olesen, H. G., Bragt, T. v., Cadour, S., Decker, P. D., . . . Hack, C. E. Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart. Nature Portfolio.
Chicago Style (17th ed.) CitationWalle, Inge Van de, et al. Randomized Phase I Trial Outcomes Show Safe and Sustainable Inhibition of Classical and Lectin Complement Pathways by Empasiprubart. Nature Portfolio.
MLA (9th ed.) CitationWalle, Inge Van de, et al. Randomized Phase I Trial Outcomes Show Safe and Sustainable Inhibition of Classical and Lectin Complement Pathways by Empasiprubart. Nature Portfolio.
Warning: These citations may not always be 100% accurate.